Our newsletters, most recent first.
• 3 addiction issues to follow in 2025
• Fentanyl deaths in US dropped faster than expected. (Oct. 17)
• Cartels recruiting chemistry students to make fentanyl more addictive
• Most Americans do not know that primary care physicians can prescribe addiction treatment.
• Preliminary data from 2024 show a decline in overdose death rates.
• Greater access to methadone is needed in the fentanyl era (Guest editorial in ASAM Weekly).
• New Methadone Regulations
• Clinical Report from AATOD Meeting Publications
• National and International Perspectives
• Involuntary Addiction Treatment: A Dangerous Idea
• Stigmatizing Imagery in Publications
• Barriers to Buprenorphine Treatment Among People of Color
• Fentanyl complicates treatment of opioid use disorder
• Rhetoric against methadone treatment
• NIDA director calls for broad deregulation of methadone treatment
• Study: Sufferers of OUD don’t receive proper evidence-based treatment
• Despite overdose deaths, few Americans addicted to opioids getting help
• What to know about Medicare Part B and coverage of opioid use disorder
• Take a look at our supporters in the fight for Medication Treatment for Opioid Addiction.
• White House Releases Drug Control Strategy
• The Methadone Manifesto
• New Mobile Methadone Rules
• U.S. Faces the Worst Naloxone Shortage
• Practice Guidelines for the Administration of Buprenorphine
• Woman recovering from opioid addiction sues to get methadone treatment in jail
• Language Matters: It Is Time We Change How We Talk About Addiction
• HHS Expands Access to Treatment for Opioid Use
• Study Tests A Model Intervention To Reduce Opioid Overdose Deaths
• Online Suboxone Doctors Make It Possible For Delivery To Home-Recovery Patients
• MAT During The Pandemic
• MAT in the news
• Massachusetts: Expanding and ensuring access to care
• MAT center fights stigma, shame and rising overdoses in South Philly
• New momentum for addiction treatment behind bars
• An opioid crisis foretold
• Monthly Buprenorphine Injections Effective for Opioid Use Disorders
